Cargando...
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
BACKGROUND: Non‐absorbable disaccharides (lactulose and lactitol) are recommended as first‐line treatment for hepatic encephalopathy. The previous (second) version of this review included 10 randomised clinical trials (RCTs) evaluating non‐absorbable disaccharides versus placebo/no intervention and...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2016
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004252/ https://ncbi.nlm.nih.gov/pubmed/27153247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003044.pub4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|